BCAX Latest Headlines

Bicara Therapeutics Inc. (BCAX) Gets a Buy from Stifel Nicolaus

at www.tipranks.com (Thu, 29-Oct 9:26 AM)

Genmab says head and neck cancer drug cuts death risk by 50% with Merck’s Keytruda

at seekingalpha.com (Wed, 28-Oct 10:10 AM)

Analyst Reaffirms Buy on Bicara, Citing Ficera’s Differentiated Efficacy and Chemo-Free Profile; Price Target Maintained at $34

at www.tipranks.com (Tue, 27-Oct 9:05 AM)

Analysts Offer Insights on NA Companies: Bicara Therapeutics Inc. (BCAX) and Microsoft (MSFT)

at www.tipranks.com (Mon, 26-Oct 8:41 PM)

Stifel Nicolaus Reaffirms Their Buy Rating on Bicara Therapeutics Inc. (BCAX)

at www.tipranks.com (Mon, 26-Oct 10:38 AM)

Wedbush Keeps Their Buy Rating on Bicara Therapeutics Inc. (BCAX)

at www.tipranks.com (Mon, 26-Oct 10:37 AM)

Analysts Offer Insights on NA Companies: Bicara Therapeutics Inc. (BCAX) and Aardvark Therapeutics, Inc. (AARD)

at www.tipranks.com (Sun, 25-Oct 8:30 PM)